Conquering the hypoxia limitation for photodynamic therapy
Photodynamic therapy (PDT) has aroused great research interest in recent years owing to its
high spatiotemporal selectivity, minimal invasiveness, and low systemic toxicity. However …
high spatiotemporal selectivity, minimal invasiveness, and low systemic toxicity. However …
[HTML][HTML] Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
B Ji, M Wei, B Yang - Theranostics, 2022 - ncbi.nlm.nih.gov
Cancer immunotherapy has made tremendous clinical progress in advanced-stage
malignancies. However, patients with various tumors exhibit a low response rate to …
malignancies. However, patients with various tumors exhibit a low response rate to …
The use of alternative strategies for enhanced nanoparticle delivery to solid tumors
M Izci, C Maksoudian, BB Manshian… - Chemical …, 2021 - ACS Publications
Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a
decade. Classically, scientists have tried to improve NM delivery by employing passive or …
decade. Classically, scientists have tried to improve NM delivery by employing passive or …
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy
S Zhang, J Wang, Z Kong, X Sun, Z He, B Sun, C Luo… - Biomaterials, 2022 - Elsevier
Immunotherapy has emerged as a promising cancer treatment modality. Despite the rapid
progress in cancer immunotherapy, the therapeutic efficiency and clinical translation of …
progress in cancer immunotherapy, the therapeutic efficiency and clinical translation of …
Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment
S Gao, X Yang, J Xu, N Qiu, G Zhai - ACS nano, 2021 - ACS Publications
Immunotherapy that harnesses the human immune system to fight cancer has received
widespread attention and become a mainstream strategy for cancer treatment. Cancer …
widespread attention and become a mainstream strategy for cancer treatment. Cancer …
[HTML][HTML] Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling
S Fu, L Chang, S Liu, T Gao, X Sang, Z Zhang… - Nature …, 2023 - nature.com
Targeting tumour immunosuppressive microenvironment is a crucial strategy in
immunotherapy. However, the critical role of the tumour lymph node (LN) immune …
immunotherapy. However, the critical role of the tumour lymph node (LN) immune …
[HTML][HTML] Cell membrane coated-nanoparticles for cancer immunotherapy
Y Zeng, S Li, S Zhang, L Wang, H Yuan, F Hu - Acta Pharmaceutica Sinica …, 2022 - Elsevier
Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …
autoimmune system, with low toxicity and high effectiveness. Some of cancer …
Nanoplatform-based cascade engineering for cancer therapy
J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2020 - pubs.rsc.org
Various therapeutic techniques have been studied for treating cancer precisely and
effectively, such as targeted drug delivery, phototherapy, tumor-specific catalytic therapy …
effectively, such as targeted drug delivery, phototherapy, tumor-specific catalytic therapy …
[HTML][HTML] Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Q Lu, D Kou, S Lou, M Ashrafizadeh, AR Aref… - Journal of Hematology & …, 2024 - Springer
Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …
against cancers. Despite these advancements, challenges remain, particularly in the clinical …
Photothermal-chemotherapy enhancing tumor immunotherapy by multifunctional metal–organic framework based drug delivery system
Immunotherapy holds great promise for patients undergoing tumor treatment. However, the
clinical effect of immunotherapy is limited because of tumor immunogenicity and its …
clinical effect of immunotherapy is limited because of tumor immunogenicity and its …